Semi-Annual Consolidated Statement Of Cash Flows

WAKAMOTO PHARMACEUTICAL CO.,LTD. - Filing #7320752

Concept As at
2024-03-31
2023-04-01 to
2024-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
As at
2022-03-31
Semi-annual consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
158,854,000 JPY
211,574,000 JPY
Depreciation
411,587,000 JPY
445,752,000 JPY
Impairment losses
JPY
31,000,000 JPY
Increase (decrease) in allowance for doubtful accounts
-2,400,000 JPY
-1,100,000 JPY
Interest and dividend income
-53,746,000 JPY
-47,926,000 JPY
Interest expenses
531,000 JPY
578,000 JPY
Increase (decrease) in provision for bonuses
-67,000,000 JPY
103,900,000 JPY
Decrease (increase) in trade receivables
381,887,000 JPY
-532,097,000 JPY
Decrease (increase) in inventories
-53,158,000 JPY
298,133,000 JPY
Increase (decrease) in trade payables
-185,636,000 JPY
-112,694,000 JPY
Other, net
-136,112,000 JPY
253,952,000 JPY
Subtotal
-44,089,000 JPY
634,621,000 JPY
Interest and dividends received
53,746,000 JPY
47,926,000 JPY
Interest paid
-531,000 JPY
-578,000 JPY
Income taxes paid
-116,464,000 JPY
-53,354,000 JPY
Net cash provided by (used in) operating activities
-107,338,000 JPY
631,920,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-330,750,000 JPY
-85,307,000 JPY
Purchase of investment securities
-2,857,000 JPY
-3,155,000 JPY
Proceeds from sale of investment securities
575,677,000 JPY
JPY
Net cash provided by (used in) investing activities
-2,352,000 JPY
17,131,000 JPY
Cash flows from financing activities
Purchase of treasury shares
-36,000 JPY
-75,000 JPY
Dividends paid
-103,901,000 JPY
-480,000 JPY
Net cash provided by (used in) financing activities
-104,986,000 JPY
-1,615,000 JPY
Net increase (decrease) in cash and cash equivalents
-214,677,000 JPY
647,436,000 JPY
Cash and cash equivalents
3,664,647,000 JPY
3,879,325,000 JPY
3,231,889,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.